---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-085900"
form_type: "8-K"
ticker: "DRIO"
cik: "0001533998"
company_name: "DarioHealth Corp."
filed_at: "2026-07-22T21:19:14+00:00"
generated_at: "2026-07-22T21:20:13.362979+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# DarioHealth prices $23.5M registered direct offering of common stock and pre-funded warrants

## Summary
- Gross proceeds ~$23.5M from sale of 3.45M shares (or equivalents) at $6.80/share.
- Offering includes 2.44M shares and pre-funded warrants for 1.02M shares; board member purchased 14,430 shares at $6.93.
- Net proceeds for working capital, investments, acquisitions, and general corporate purposes.
- Closing expected July 23, 2026; A.G.P./Alliance Global Partners as sole placement agent with 6% fee.
- 30-day restricted period on further equity issuance (except existing ATM facility).

## SEC filing metadata
- accession: 0001104659-26-085900
- form_type: 8-K
- ticker: DRIO
- cik: 0001533998
- company_name: DarioHealth Corp.
- filed_at: 2026-07-22T21:19:14+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533998/000110465926085900/0001104659-26-085900-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533998/000110465926085900/tm2621105d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-085900
- JSON: https://secwatch.observer/filing/0001104659-26-085900.json
- Plain text: https://secwatch.observer/filing/0001104659-26-085900.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.